Allarity Therapeutics, Inc. Allarity Therapeutics is now poised to run its DRP® testing in-house in a CLIA-certified ...
Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people worldwide. While current therapies address disease symptoms, they do not ...
Skyroot is preparing for Vikram 1, a mission that will make it the first private Indian company to launch a commercial ...
Bacterial spot disease isn’t just a nuisance for tomato growers – it’s a relentless, weather-powered villain that can ruin a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results